8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Feb 2, 2026: Cencora ($COR) acquired the majority of OneOncology for ~ $4.6B cash; affiliated practices…
Filed with the SEC on · Summarized by InvestorsBot
Feb 2, 2026: Cencora ($COR) acquired the majority of OneOncology for ~ $4.6B cash; affiliated practices and management retain a minority interest. Deal expands Cencora's oncology platform. 🧬🩺 #M&A #Oncology
Cencora ($COR) funded the ~ $4.6B OneOncology purchase with new debt financing. OneOncology’s results will be consolidated in the U.S. Healthcare Solutions segment—expect impact on leverage and segment earnings. 💵📈 #Healthcare #Debt
Feb 4, 2026 8:30 AM ET: Cencora ($COR) will host a conference call/webcast on results for the fiscal quarter ended Dec 31, 2025. Slides & webcast available at investor.cencora.com. 🔊🕗 #Earnings #Webcast